Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
Part of paid clinical trials in North Little Rock, Arkansas.
- Sponsor
- Incyte Corporation
- Study ID
- NCT05456529
- Phase
- PHASE3
- Status
- Completed
Conditions
- Atopic Dermatitis (AD)
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ruxolitinib Cream — DRUGRuxolitinib cream 1.5% twice daily (BID) during the continuous and LTS treatment period.
Study Details
The purpose of this study is to evaluate the long-term safety and tolerability of ruxolitinib cream in adolescents with Atopic Dermatitis (AD).
Key Dates
- Start date
- Sep 1, 2022
- Status verified
- Jun 2025
- Primary completion
- May 17, 2024
- Completion
- May 17, 2024
Study Design
- Enrollment
- 103 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: RuxolitinibRuxolitinib cream 1.5% twice daily (BID) during the continuous and LTS treatment period.
Primary Outcome Measure
Number of Participants With Treatment-emergent Adverse Events (TEAEs) [ Time Frame: up to 462 days ]
Locations (26)
Find similar trials in North Little Rock, AR
By research site
Arkansas Research Trials· North Little Rock, ARFirst Oc Dermatology· Fountain Valley, CADermatology Research Associates· Los Angeles, CAPeninsula Research Associates Pra· Rolling Hills Estates, CAAdvanced Rx Clinical Research Group, Inc· Westminster, CAEncore Medical Research, Llc Hollywood· Hollywood, FL
Related Studies
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and PsoriasisPHASE1 · Recruiting · LAPIX Therapeutics Inc. · Fargo, North Dakota
- A Study Evaluating BFB759 in Moderate to Severe Atopic DermatitisPHASE2 · Recruiting · Bluefin Biomedicine, Inc. · Phoenix, Arizona
- Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · Recruiting · Enveda Therapeutics · Birmingham, Alabama
- The Impact of Botox on Neuroimmune Interactions in Atopic DermatitisPHASE1 · Recruiting · Daniel Kaplan · Pittsburgh, Pennsylvania